---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-027762"
form_type: "8-K"
ticker: "HUMA"
cik: "0001818382"
company_name: "Humacyte, Inc."
filed_at: "2025-03-25T23:59:59+00:00"
generated_at: "2026-05-24T05:58:08.808114+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "low"
source: SEC EDGAR
---

# Humacyte files investor presentation; no specific financial or operational details available in filing

## Summary
- Investor presentation dated March 2025 made available; content not fully disclosed in this filing.
- Presentation covers Humacyte's regenerative human tissue platform; no new material facts extracted.
- Filing occurs under Item 8.01 as a routine update; no guidance or earnings included.
- Tickers HUMA and HUMAW referenced; no price or volume data provided.

## SEC filing metadata
- accession: 0001104659-25-027762
- form_type: 8-K
- ticker: HUMA
- cik: 0001818382
- company_name: Humacyte, Inc.
- filed_at: 2025-03-25T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818382/000110465925027762/0001104659-25-027762-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818382/000110465925027762/tm258849d2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-027762
- JSON: https://secwatch.observer/filing/0001104659-25-027762.json
- Plain text: https://secwatch.observer/filing/0001104659-25-027762.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.